PortfoliosStock ScreensStocksStockXcel

Humacyte Inc

HUMAW | US

0.12

USD

0.01

8.65%

HUMAW | US
Loading StockChartView...

About Humacyte Inc

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

09/03/2026

Close

0.12

Open

0.11

High

0.12

Low

0.10

Humacyte Inc. a clinical-stage biotechnology platform company develops and manufactures off-the-shelf bioengineered human tissues. The company develops and manufactures acellular tissues to address life- and limb-threatening vascular conditions for complex organ disease. Its Human Acellular Vessel (HAV) a regenerative vascular conduit that is in late-stage clinical trials targeting multiple vascular applications including vascular trauma repair arteriovenous access for hemodialysis and peripheral arterial disease. The company was founded in 2004 and is based in Durham North Carolina.

View Less

HUMAW | US

Risk
207.0
Sharpe
-0.49
Luna's Score
46/100
Recommendation
Hold

Luna says (HUMAW | US)

What's Working

Low Debt to Equity (< 0.25)

Strong Revenue Growth (> 10%)

What's not Working

High Short-term Volatility

High 6-Month Volatility (>65%)

Microcap (<300M USD)

High Market Beta (> 0.8)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

Loading RiskMeterView...

10 days

185.8%

1 month

207.0%

3 months

160.3%

6 months

147.0%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

-

Debt to equity

-0.63

Debt to assets

0.13

Ent. to EBITDA

-

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-99.65M

MarketCap

-

MarketCap(USD)

-

Div. yield

-

Op. margin

-

Erngs. growth

-

Rev. growth

248.50

Ret. on equity

-850.81

Short ratio

-

Short perc.

-

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

0.04

Range1M

0.04

Range3M

0.07

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

0.38

Price X volume

590.97

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
XOMAPXOMAPBiotechnology25.88500.45%26.27121.93%
XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred StockXOMAOBiotechnology25.30-0.49%25.57121.93%
SABSWSABSWBiotechnology0.031800.1711.58%
Revolution Medicines Inc. WarrantRVMDWBiotechnology1.8301.67%n/a5.40%
REVBWREVBWBiotechnology0.00910n/a0.00%
Rocket Pharmaceuticals Inc. WarrantRCKTWBiotechnology0.01990-0.50%n/a0.00%
ICUCWICUCWBiotechnology0.029507.27%n/a-45.50%
EyeGate Pharmaceuticals IncEYEGBiotechnology35.7300.38%n/a
COEPWCOEPWBiotechnology0.0123024.24%n/a25.11%

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
No data

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA-0.53-
Ent. to Revenue-3,967.00-
PE Ratio-41.03-
Price to Book-15.55-
Dividend Yield-2.20-
Std. Deviation (3M)160.3272.80Riskier
Debt to Equity-0.63-1.23Expensive
Debt to Assets0.130.25Cheaper
Market Cap-3.66B-

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007